Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2657079933;79934;79935 chr2:178566424;178566423;178566422chr2:179431151;179431150;179431149
N2AB2492975010;75011;75012 chr2:178566424;178566423;178566422chr2:179431151;179431150;179431149
N2A2400272229;72230;72231 chr2:178566424;178566423;178566422chr2:179431151;179431150;179431149
N2B1750552738;52739;52740 chr2:178566424;178566423;178566422chr2:179431151;179431150;179431149
Novex-11763053113;53114;53115 chr2:178566424;178566423;178566422chr2:179431151;179431150;179431149
Novex-21769753314;53315;53316 chr2:178566424;178566423;178566422chr2:179431151;179431150;179431149
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGT
  • RefSeq wild type template codon: CCA
  • Domain: Fn3-81
  • Domain position: 84
  • Structural Position: 115
  • Q(SASA): 0.1527
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/D None None 1.0 D 0.915 0.686 0.457106177737 gnomAD-4.0.0 1.20032E-06 None None None None I None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.7645 likely_pathogenic 0.7571 pathogenic -0.596 Destabilizing 1.0 D 0.752 deleterious D 0.550202402 None None I
G/C 0.8751 likely_pathogenic 0.8763 pathogenic -0.929 Destabilizing 1.0 D 0.868 deleterious D 0.562572666 None None I
G/D 0.9193 likely_pathogenic 0.9332 pathogenic -0.759 Destabilizing 1.0 D 0.915 deleterious D 0.542693984 None None I
G/E 0.9537 likely_pathogenic 0.9548 pathogenic -0.862 Destabilizing 1.0 D 0.903 deleterious None None None None I
G/F 0.983 likely_pathogenic 0.983 pathogenic -0.998 Destabilizing 1.0 D 0.89 deleterious None None None None I
G/H 0.9792 likely_pathogenic 0.9827 pathogenic -0.961 Destabilizing 1.0 D 0.874 deleterious None None None None I
G/I 0.9765 likely_pathogenic 0.9765 pathogenic -0.424 Destabilizing 1.0 D 0.892 deleterious None None None None I
G/K 0.9852 likely_pathogenic 0.9871 pathogenic -1.183 Destabilizing 1.0 D 0.903 deleterious None None None None I
G/L 0.9718 likely_pathogenic 0.9721 pathogenic -0.424 Destabilizing 1.0 D 0.867 deleterious None None None None I
G/M 0.983 likely_pathogenic 0.9824 pathogenic -0.427 Destabilizing 1.0 D 0.867 deleterious None None None None I
G/N 0.9572 likely_pathogenic 0.9654 pathogenic -0.837 Destabilizing 1.0 D 0.855 deleterious None None None None I
G/P 0.9946 likely_pathogenic 0.9963 pathogenic -0.442 Destabilizing 1.0 D 0.905 deleterious None None None None I
G/Q 0.9655 likely_pathogenic 0.9681 pathogenic -1.058 Destabilizing 1.0 D 0.915 deleterious None None None None I
G/R 0.9644 likely_pathogenic 0.9655 pathogenic -0.764 Destabilizing 1.0 D 0.917 deleterious D 0.561051729 None None I
G/S 0.6338 likely_pathogenic 0.6733 pathogenic -1.078 Destabilizing 1.0 D 0.853 deleterious D 0.538174534 None None I
G/T 0.9057 likely_pathogenic 0.9161 pathogenic -1.102 Destabilizing 1.0 D 0.902 deleterious None None None None I
G/V 0.9574 likely_pathogenic 0.9564 pathogenic -0.442 Destabilizing 1.0 D 0.88 deleterious D 0.528085676 None None I
G/W 0.9711 likely_pathogenic 0.9742 pathogenic -1.252 Destabilizing 1.0 D 0.883 deleterious None None None None I
G/Y 0.9703 likely_pathogenic 0.9712 pathogenic -0.882 Destabilizing 1.0 D 0.89 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.